These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2003803)

  • 21. Collagen shield heparin delivery for prevention of postoperative fibrin.
    Murray TG; Stern WH; Chin DH; MacGowan-Smith EA
    Arch Ophthalmol; 1990 Jan; 108(1):104-6. PubMed ID: 2297315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective, open-label, dose-escalating study of low molecular weight heparin during repeat vitrectomy for PVR and severe diabetic retinopathy.
    Lane RG; Jumper JM; Nasir MA; MacCumber MW; McCuen BW
    Graefes Arch Clin Exp Ophthalmol; 2005 Jul; 243(7):701-5. PubMed ID: 15744529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined extracapsular cataract extraction, posterior chamber intraocular lens implantation, and pars plana vitrectomy.
    Foster RE; Lowder CY; Meisler DM; Zakov ZN; Meyers SM; Ambler JS
    Ophthalmic Surg; 1993 Jul; 24(7):446-52. PubMed ID: 8351090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissolution of intraocular fibrinous exudate by streptokinase.
    Cherfan GM; el Maghraby A; Tabbara KF; Nasr Y; Hassan H
    Ophthalmology; 1991 Jun; 98(6):870-4. PubMed ID: 1866139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Posterior chamber lens implantation concurrent with vitrectomy for proliferative diabetic retinopathy].
    Katsu Y; Ogino N; Kumagai E
    Nippon Ganka Gakkai Zasshi; 1991 Jan; 95(1):86-91. PubMed ID: 2042534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined cataract surgery and vitrectomy for breakthrough vitreous hemorrhage from age-related macular degeneration.
    Chaudhry NA; Flynn HW; Murray TG; Belfort A
    Ophthalmic Surg Lasers; 2002; 33(1):16-8. PubMed ID: 11820658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of postvitrectomy diabetic vitreous hemorrhage with tissue plasminogen activator (t-PA) and volume homeostatic fluid-fluid exchanger.
    Wu WC; Chang SM; Chen JY; Chang CW
    J Ocul Pharmacol Ther; 2001 Aug; 17(4):363-71. PubMed ID: 11572467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Low molecular weight heparin inhibits raised intraocular pressure following intracameral administration of sodium hyaluronate].
    Kondo H; Hayashi H; Oshima K
    Nippon Ganka Gakkai Zasshi; 1994 May; 98(5):423-8. PubMed ID: 8197910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of clear corneal phacoemulsification combined with 25-gauge transconjunctival sutureless vitrectomy and standard 20-gauge vitrectomy for patients with cataract and vitreoretinal diseases.
    Chang CJ; Chang YH; Chiang SY; Lin LT
    J Cataract Refract Surg; 2005 Jun; 31(6):1198-207. PubMed ID: 16039498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pars plana lensectomy and intraocular lens implantation in pediatric radiation-induced cataracts in retinoblastoma.
    Miller DM; Murray TG; Cicciarelli NL; Capo H; Markoe AM
    Ophthalmology; 2005 Sep; 112(9):1620-4. PubMed ID: 16024083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of post-vitrectomy persistent vitreous hemorrhage in pseudophakic eyes.
    Landers MB; Perraki AD
    Am J Ophthalmol; 2003 Dec; 136(6):989-93. PubMed ID: 14644207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Posterior chamber intraocular lens implantation in eyes with inactive and active proliferative diabetic retinopathy.
    Ruiz RS; Saatci OA
    Am J Ophthalmol; 1991 Feb; 111(2):158-62. PubMed ID: 1992735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracameral tissue plasminogen activator to prevent severe fibrinous effusion after congenital cataract surgery.
    Siatiri H; Beheshtnezhad AH; Asghari H; Siatiri N; Moghimi S; Piri N
    Br J Ophthalmol; 2005 Nov; 89(11):1458-61. PubMed ID: 16234453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined phacoemulsification, pars plana vitrectomy, and posterior chamber intraocular lens insertion.
    Koenig SB; Mieler WF; Han DP; Abrams GW
    Arch Ophthalmol; 1992 Aug; 110(8):1101-4. PubMed ID: 1497524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined 23-gauge sutureless vitrectomy and clear corneal phacoemulsification in patients with proliferative diabetic retinopathy.
    Lee DY; Jeong HS; Sohn HJ; Nam DH
    Retina; 2011 Oct; 31(9):1753-8. PubMed ID: 21555968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A SURGICAL APPROACH TO LARGE SUBRETINAL HEMORRHAGE USING PARS PLANA VITRECTOMY AND 360° RETINOTOMY.
    Wei Y; Zhang Z; Jiang X; Li F; Zhang T; Qiu S; Yang Y; Zhang S
    Retina; 2015 Aug; 35(8):1631-9. PubMed ID: 26214315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triple procedure in posterior segment intraocular foreign body.
    Azad R; Sharma YR; Mitra S; Pai A
    Indian J Ophthalmol; 1998 Jun; 46(2):91-2. PubMed ID: 9847481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of pediatric cataract surgery with intraocular injection of triamcinolone acetonide: Randomized controlled trial.
    Allam G; Ellakkany R; Ellayeh A; Mohsen T; Abouelkheir HE; Gaafar W
    Eur J Ophthalmol; 2018 Nov; 28(6):633-638. PubMed ID: 29619840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of postvitrectomy fibrin pupillary block with tissue plasminogen activator.
    Jaffe GJ; Lewis H; Han DP; Williams GA; Abrams GW
    Am J Ophthalmol; 1989 Aug; 108(2):170-5. PubMed ID: 2502924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endodiathermy plus photocoagulation as treatment of sclerotomy site vascularization secondary to pars plana vitrectomy for proliferative diabetic retinopathy.
    Nadal J; Carreras E; Canut MI
    Retina; 2012 Jul; 32(7):1310-5. PubMed ID: 22466471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.